Company
DenmarkPublic company, NASDAQ: GMABGenmab A/S (NASDAQ: GMAB), Copenhagen K, Denmark – FDA Inspections
Inspection records and compliance data for Genmab A/S in Copenhagen K. 1 FDA inspection on record, last inspected June 24, 2009. Publicly traded as NASDAQ: GMAB.
Company Profile
This profile covers Genmab A/S based in Copenhagen K, Denmark.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected June 24, 2009.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 24, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 595458 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Genmab A/S
Stock ticker
GMAB
Exchange
NASDAQ
Share price
$51.74
Market cap
$32.3B
Price as of
November 13, 2026
FEI Number
3007626754
Address
Bredgade 34, P.O. Box 9068, Copenhagen K, Denmark
Country
Denmark
ID: f4d7b380-fbee-47a0-9560-d1fdf1251f8d